American Aires (AAIRF) said on Monday it entered into a non-binding letter dated June 25, 2026, for the proposed sale of certain assets to an arm’s-length third-party purchaser. The proposed sale includes intellectual property, technology, product materials, inventory, customer data, and other assets. Pursuant to the transaction, the company intends…

By Jeff Altman, The Big Game Hunter   I took my wife to the airport on Wednesday for her annual visit to Ulverston in the UK. She is a Buddhist meditation teacher and they do teacher training there for a few weeks before an annual festival and celebration. We’ll speak…

The crypto market outlook remains fragile. Rising concerns about Federal Reserve interest-rate increases, a strengthening dollar, higher U.S. Treasury yields, record ETF outflows and airstrikes in the Middle East offer bitcoin BTC$59,760.11 bulls little reason for optimism. Yet the market dynamics carry a glimmer of hope. Bullish positioning, especially in…

Palantir looks to boost commercialization of new software; teams with Nvidia on Nemotron Source link

The locked capital needed for a MiCA spot license is relatively small, somewhere between 50,000 euros ($57,000) and 150,000 euros by class, according to Patrick Gruhn, founder and CEO of Perpetuals.com Ltd. (PDC). What becomes costly is the license itself, which can be as high as 700,000 euros in year…

Emanuel M Schwermer/DigitalVision via Getty Images Jefferies upgraded Mercedes-Benz (MBGAF) to a Buy rating on Monday. Analyst Philippe Houchois noted that the auto stock has tracked BMW’s recent earnings warning, but messaging at the firm’s GermanSwiss conference last week felt supportive and consistent with reiteration of margin Source link

Crypto market participants are entering July with a critical shift in Europe as the MiCA framework’s transitional period expires. Exchanges are now competing to lure in Binance users in the region after the firm failed to secure a license. On top of that, investors will see new product reveals from…

Richard Drury Ipsen (IPSEY) to acquire U.S.-based Kartos Therapeutics for $450M in cash, expanding its late-stage oncology portfolio with a Phase III blood cancer therapy. Ipsen (IPSEY) said the acquisition aligns with its strategy to build a stronger late-stage oncology franchise Source link

AM Need to Know: South Korea's chip push, xAI's Grok 4.5 & more Source link

By Jeff Altman, The Big Game Hunter Click here if the video does not play properly LinkedIn’s systems have changed what they want to see in a profile to refer you. Keyword stuffing your LinkedIn profile doesn’t work like it once did because they’ve changed how they refer people and…